ChIP-seq analyses in primary endometrial tissue.

Slides:



Advertisements
Similar presentations
Figure S1 A B C D E F G Long Day Hypocotyl lenght (mm)
Advertisements

Figure 1. Annotation and characterization of genomic target of p63 in mouse keratinocytes (MK) based on ChIP-Seq. (A) Scatterplot representing high degree.
Volume 43, Issue 1, Pages (July 2011)
Dynamic epigenetic enhancer signatures reveal key transcription factors associated with monocytic differentiation states by Thu-Hang Pham, Christopher.
Analysis of the deep-sequencing data.
Volume 23, Issue 1, Pages (January 2013)
HIS-24 regulates expression of infection-inducible genes.
Volume 11, Issue 2, Pages (August 2012)
Taichi Umeyama, Takashi Ito  Cell Reports 
Volume 58, Issue 2, Pages (April 2015)
Volume 7, Issue 5, Pages (June 2014)
Volume 54, Issue 1, Pages (April 2014)
Gene expression and genomic profiling reveal estrogen-independent ER transcriptional activity. Gene expression and genomic profiling reveal estrogen-independent.
Sequence features that were correlated with ASD.
OTX2 is associated with higher levels of activity when paired with NEUROD1 and arranged in clusters. OTX2 is associated with higher levels of activity.
Genome-Wide Analysis of PLT2 Binding to Target Genes.
Chromatin binding sites shared by pCREB1 and ERα are predominantly cAMP induced. Chromatin binding sites shared by pCREB1 and ERα are predominantly cAMP.
Expression and occupancy of a set of transcription factors corresponding to the identified motifs at FAIRE peaks Expression and occupancy of a set of transcription.
Volume 20, Issue 6, Pages (August 2017)
Volume 17, Issue 5, Pages (October 2016)
Figure 4. (A) Venn diagram showing the overlap of peaks differentially changed in DHT as compared to NT with peaks ... Figure 4. (A) Venn diagram showing.
NCoR1 controls basal expression of T3-target genes.
Fine-Resolution Mapping of TF Binding and Chromatin Interactions
Volume 24, Issue 3, Pages (February 2013)
Figure 2. Ectopic expression of PLZF modulates H3K27ac at enhancer regions in myeloid cells. (A) Box plots showing ... Figure 2. Ectopic expression of.
Volume 62, Issue 1, Pages (April 2016)
Fine-Resolution Mapping of TF Binding and Chromatin Interactions
Volume 128, Issue 6, Pages (March 2007)
Generating ChIP-seq profiles from 18G core needle biopsies from radical prostatectomy samples. Generating ChIP-seq profiles from 18G core needle biopsies.
Human Promoters Are Intrinsically Directional
Volume 17, Issue 10, Pages (December 2016)
Volume 14, Issue 6, Pages (June 2014)
Volume 21, Issue 6, Pages e6 (December 2017)
Coverage plots of H3K27ac ChIP-seq data in endometrial cancer specimens. Coverage plots of H3K27ac ChIP-seq data in endometrial cancer specimens. For the.
Volume 35, Issue 2, Pages (August 2011)
Volume 14, Issue 6, Pages (June 2014)
Volume 64, Issue 5, Pages (December 2016)
RNA-seq results at the SAM
Identification of FD targets by pSUC2::GFP:FD ChIP-seq in Col-0 and ft-10 tsf-1 and pFD::GFP:FD ChIP-seq in fd-2. Identification of FD targets by pSUC2::GFP:FD.
Volume 6, Issue 4, Pages (April 2016)
Genomewide profiling of chromatin accessibility in prostate cancer specimens Genomewide profiling of chromatin accessibility in prostate cancer specimens.
Increased signal intensity and significant enrichment of transcription factor motifs is observed with DSG in breast tissue. Increased signal intensity.
Increased signal intensity and significant enrichment of transcription factor motifs is observed with DSG in primary prostate tissue. Increased signal.
Coverage plots of H3K27ac ChIP-seq data in breast cancer specimens.
ChIP-seq analyses in primary breast tissue.
Transcriptome changes in Cnot6l knockout oocytes and zygotes.
Chromatin shearing is not affected between the two fixation methods.
CTCF Binding Polarity Determines Chromatin Looping
ChIP-seq analyses in primary in prostate tissue.
Increased signal intensity and significant enrichment of transcription factor motifs is observed with DSG in endometrial tissue. Increased signal intensity.
Fig. 3 Conserved genomic association of PRC1 activity in different leukemic cells. Conserved genomic association of PRC1 activity in different leukemic.
Properties of leucocyte subset-specific type 1 interferon (IFN-1) modules. Properties of leucocyte subset-specific type 1 interferon (IFN-1) modules. (A)
Figure 1. Genome-wide analyses of mammary-specific super-enhancers at L1 and L10. (A) Coverage plots of the mammary ... Figure 1. Genome-wide analyses.
ChIP-seq for H3K4me and H3K27ac assigns potential enhancers to transcripts under control of HoxA9. ChIP-seq for H3K4me and H3K27ac assigns potential enhancers.
Uhrf1-mediated DNA methylation governs chondrocyte differentiation.
CD4+CLA+CD103+ T cells from human blood and skin share a transcriptional profile. CD4+CLA+CD103+ T cells from human blood and skin share a transcriptional.
Coverage plots of H3K27ac ChIP-seq data in prostate cancer specimens.
Increased signal intensity and significant enrichment of transcription factor motifs is observed with DSG in cell line models. Increased signal intensity.
Taichi Umeyama, Takashi Ito  Cell Reports 
Volume 8, Issue 1, Pages (July 2014)
Volume 58, Issue 2, Pages (April 2015)
Transcriptional and genomic targets of EN1 in TNBC cells.
Transcripts enriched and depleted in NB TICs compared with SKPs and other tumor tissues. Transcripts enriched and depleted in NB TICs compared with SKPs.
Chromatin state mapping pinpoints PAX3–FOXO1 (P3F) in active enhancers
SY-1425 shows similar response in RARA-high AML cell lines to APL
BRD4 expression and genomic distribution in B-CLL.
EZH2-driven lung cancer as a molecularly distinct entity.
Fig. 2 Combined transcriptome profiling, ChIP-seq, and ATAC-seq analysis identifies 14 highly plausible direct targets of Runx. Combined transcriptome.
Fig. 5 Enhancers and super-enhancers identified in various brain cell populations. Enhancers and super-enhancers identified in various brain cell populations.
Presentation transcript:

ChIP-seq analyses in primary endometrial tissue. ChIP-seq analyses in primary endometrial tissue. (A) Genome browser snapshots of ERα and H3K27ac sites in endometrial tumors, in FA-fixed samples with and without DSG treatment (FA: blue. FA+DSG: red). (B) Venn diagram showing the overlap of sites for ERα and H3K27ac using FA (blue) and FA along with DSG (red). (C) Intensity plots showing the read densities over the peaks (±5 kb) in profiles generated using FA (−) and FA along with DSG (+). The fraction of reads in peaks (FRiP score) is placed above each intensity plot. (D) Genomic distribution of sites for ERα and H3K27ac in FA/DSG fixed samples (FA+DSG). (E) Percentage sites of ERα sites in FA/DSG fixed samples positive for ESR1 motifs. (F) Venn diagram of union of all ERα sites previously reported in endometrial tumors and sites identified in FA/DSG-fixed samples. The intensity plot shows the read density of the previously published ERα binding sites (±5 kb). Abhishek A Singh et al. LSA 2019;2:e201800115 © 2018 Singh et al.